Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.